Enzyme Replacement Therapy in Perinatal Hypophosphatasia: Case Report of a Negative Outcome and Lessons for Clinical Practice

 

Click HERE

 

 

 

 

 

Monitoring Guidance for Patients with Hypophosphatasia Treated with Asfotase Alfa.

 

Click HERE.

 

 

 

 

 

Hypophosphatasia: Enzyme Replacement Therapy Brings New Opportunities and New Challenges

Dr. M. Whyte, 2017

 

4-Part Series by the Canadian Dental Association on HPP

Click Here

Endocrine Society Presents Diagnosis and Management of Hypophosphatasia: Improving Patient Outcomes

Click Here

 

 

Hypophosphatasia: Diagnosis and Clinical Signs – A Dental Surgeon Perspective

Click Here

Hypophosphatasia

Etienne Mornet, PhD and Mark E Nunes, MD.

Initial Posting: November 20, 2007; Last Update: February 4, 2016.

Click Here

 

Clinical, Radiographic and Biochemical Characteristics of Adult Hypophosphatasia

Click Here.

Manitoba Cleft Lip and Palate/Dysplasia Dental Benefit Program

 

Click Here

ADULT HYPOPHOSPHATASIA TREATED WITH TERIPARATIDE: REPORT OF 2 PATIENTS AND REVIEW OF THE LITERATURE.

Click Here.

 

 

Hypophosphatasia: An overview For 2017

Click Here

Hypophosphatasia: Enzyme Replacement Therapy Brings New Opportunities and New Challenges

Click Here

Brief Relief Promised for Six Canadians with Rare Soft-Bone Disease

Kelly Grant

THE GLOBE AND MAIL

 

 

 

Why drugs like these for orphan diseases are a booming business with colossal costs for patients

 

Kelly Grant

THE GLOBE AND MAIL

Last updated Tuesday, April 18, 2017 2:46PM EDT

https://beta.theglobeandmail.com/news/national/orphan-diseases-expensive-drugs/article34628538/?ref=http://www.theglobeandmail.com&click=sf_globe&service=mobile